Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram versus placebo for irritable bowel syndrome with comorbid panic disorder
2010-020906-14Phase 2Completed
- Sponsor
- Maastricht University Medical Center+
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in irritable bowel syndrome (IBS) and panic disorder comparing Escitalopram with Placebo (2 arms). Primary endpoint: Gastrointestinal Symptom Rating Scale (GSRS). Started Jun 2010; status: completed.
02
Drugs
escitalopram
03
Conditions
irritable bowel syndrome (IBS)panic disorder
Beyond the preview
Go deeper on 2010-020906-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020906-14.